TIME FROM DIAGNOSIS TO 2ND TREATMENT IS A PROMISING SURROGATE FOR OVERALL SURVIVAL IN PATIENTS WITH ADVANCED STAGE FOLLICULAR LYMPHOMA
Sign Up to like & getrecommendations! Published in 2017 at "Hematological Oncology"
DOI: 10.1002/hon.2438_93
Abstract: FLIPI risk category progressed in 60.5% (N = 69), which was associated with inferior outcome compared with pts with stable FLIPI (39.5%, N = 45), p = 0.006 (Figure 1C). In contrast, annual FLIPI risk… read more here.
Keywords: risk; diagnosis 2nd; treatment; time diagnosis ... See more keywords